Catalyst Wire Dossier Catalyst Wire Dossier

Ixabepilone (Ixempra)

ixabepilone · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Ixabepilone (Ixempra), covering 2011-04-04 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP. [Phase 2]

See pricing